JK Paper Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 22, 2025, 7:50 am

Competitors of JK Paper Ltd

All Competitor Stocks of JK Paper Ltd

Quarterly Result

Last Updated: August 2, 2025, 1:15 am

Below is a detailed analysis of the quarterly data for JK Paper Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 1,674.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,690.00 Cr. (Mar 2025) to 1,674.00 Cr., marking a decrease of 16.00 Cr..
• For Expenses, as of Jun 2025, the value is 1,427.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1,473.00 Cr. (Mar 2025) to 1,427.00 Cr., marking a decrease of 46.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 247.00 Cr.. The value appears strong and on an upward trend. It has increased from 217.00 Cr. (Mar 2025) to 247.00 Cr., marking an increase of 30.00 Cr..
• For OPM %, as of Jun 2025, the value is 15.00%. The value appears strong and on an upward trend. It has increased from 13.00% (Mar 2025) to 15.00%, marking an increase of 2.00%.
• For Other Income, as of Jun 2025, the value is 25.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 25.00 Cr..
• For Interest, as of Jun 2025, the value is 67.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 50.00 Cr. (Mar 2025) to 67.00 Cr., marking an increase of 17.00 Cr..
• For Depreciation, as of Jun 2025, the value is 89.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 86.00 Cr. (Mar 2025) to 89.00 Cr., marking an increase of 3.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 116.00 Cr.. The value appears strong and on an upward trend. It has increased from 105.00 Cr. (Mar 2025) to 116.00 Cr., marking an increase of 11.00 Cr..
• For Tax %, as of Jun 2025, the value is 26.00%. The value appears to be improving (decreasing) as expected. It has decreased from 27.00% (Mar 2025) to 26.00%, marking a decrease of 1.00%.
• For Net Profit, as of Jun 2025, the value is 85.00 Cr.. The value appears strong and on an upward trend. It has increased from 77.00 Cr. (Mar 2025) to 85.00 Cr., marking an increase of 8.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 4.80. The value appears strong and on an upward trend. It has increased from 4.50 (Mar 2025) to 4.80, marking an increase of 0.30.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: November 15, 2025, 5:54 am

Growth

Last Updated: September 4, 2025, 9:25 pm

Balance Sheet

Last Updated: November 9, 2025, 1:30 pm

Below is a detailed analysis of the balance sheet data for JK Paper Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

• For Equity Capital, as of Sep 2025, the value is 169.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 169.00 Cr..
• For Reserves, as of Sep 2025, the value is 5,300.00 Cr.. The value appears strong and on an upward trend. It has increased from 5,238.00 Cr. (Mar 2025) to 5,300.00 Cr., marking an increase of 62.00 Cr..
• For Borrowings, as of Sep 2025, the value is 2,118.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 1,885.00 Cr. (Mar 2025) to 2,118.00 Cr., marking an increase of 233.00 Cr..
• For Other Liabilities, as of Sep 2025, the value is 2,199.00 Cr.. The value appears to be improving (decreasing). It has decreased from 2,249.00 Cr. (Mar 2025) to 2,199.00 Cr., marking a decrease of 50.00 Cr..
• For Total Liabilities, as of Sep 2025, the value is 9,787.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 9,542.00 Cr. (Mar 2025) to 9,787.00 Cr., marking an increase of 245.00 Cr..
• For Fixed Assets, as of Sep 2025, the value is 6,167.00 Cr.. The value appears to be declining and may need further review. It has decreased from 6,257.00 Cr. (Mar 2025) to 6,167.00 Cr., marking a decrease of 90.00 Cr..
• For CWIP, as of Sep 2025, the value is 356.00 Cr.. The value appears strong and on an upward trend. It has increased from 99.00 Cr. (Mar 2025) to 356.00 Cr., marking an increase of 257.00 Cr..
• For Investments, as of Sep 2025, the value is 806.00 Cr.. The value appears strong and on an upward trend. It has increased from 610.00 Cr. (Mar 2025) to 806.00 Cr., marking an increase of 196.00 Cr..
• For Other Assets, as of Sep 2025, the value is 2,458.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,576.00 Cr. (Mar 2025) to 2,458.00 Cr., marking a decrease of 118.00 Cr..
• For Total Assets, as of Sep 2025, the value is 9,787.00 Cr.. The value appears strong and on an upward trend. It has increased from 9,542.00 Cr. (Mar 2025) to 9,787.00 Cr., marking an increase of 245.00 Cr..

Notably, the Reserves (5,300.00 Cr.) exceed the Borrowings (2,118.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for JK Paper Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 24.19. This value is within the healthy range. It has decreased from 66.22 (Mar 24) to 24.19, marking a decrease of 42.03.
• For Diluted EPS (Rs.), as of Mar 25, the value is 22.91. This value is within the healthy range. It has decreased from 59.15 (Mar 24) to 22.91, marking a decrease of 36.24.
• For Cash EPS (Rs.), as of Mar 25, the value is 43.90. This value is within the healthy range. It has decreased from 85.20 (Mar 24) to 43.90, marking a decrease of 41.30.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 315.48. It has increased from 303.95 (Mar 24) to 315.48, marking an increase of 11.53.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 315.48. It has increased from 303.95 (Mar 24) to 315.48, marking an increase of 11.53.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 396.58. It has increased from 393.11 (Mar 24) to 396.58, marking an increase of 3.47.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 61.17. This value is within the healthy range. It has decreased from 108.79 (Mar 24) to 61.17, marking a decrease of 47.62.
• For PBIT / Share (Rs.), as of Mar 25, the value is 41.59. This value is within the healthy range. It has decreased from 90.48 (Mar 24) to 41.59, marking a decrease of 48.89.
• For PBT / Share (Rs.), as of Mar 25, the value is 31.10. This value is within the healthy range. It has decreased from 78.20 (Mar 24) to 31.10, marking a decrease of 47.10.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 24.32. This value is within the healthy range. It has decreased from 66.89 (Mar 24) to 24.32, marking a decrease of 42.57.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 24.19. This value is within the healthy range. It has decreased from 66.22 (Mar 24) to 24.19, marking a decrease of 42.03.
• For PBDIT Margin (%), as of Mar 25, the value is 15.42. This value is within the healthy range. It has decreased from 27.67 (Mar 24) to 15.42, marking a decrease of 12.25.
• For PBIT Margin (%), as of Mar 25, the value is 10.48. This value is within the healthy range. It has decreased from 23.01 (Mar 24) to 10.48, marking a decrease of 12.53.
• For PBT Margin (%), as of Mar 25, the value is 7.84. This value is below the healthy minimum of 10. It has decreased from 19.89 (Mar 24) to 7.84, marking a decrease of 12.05.
• For Net Profit Margin (%), as of Mar 25, the value is 6.13. This value is within the healthy range. It has decreased from 17.01 (Mar 24) to 6.13, marking a decrease of 10.88.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 6.10. This value is below the healthy minimum of 8. It has decreased from 16.84 (Mar 24) to 6.10, marking a decrease of 10.74.
• For Return on Networth / Equity (%), as of Mar 25, the value is 7.66. This value is below the healthy minimum of 15. It has decreased from 22.40 (Mar 24) to 7.66, marking a decrease of 14.74.
• For Return on Capital Employeed (%), as of Mar 25, the value is 8.79. This value is below the healthy minimum of 10. It has decreased from 19.52 (Mar 24) to 8.79, marking a decrease of 10.73.
• For Return On Assets (%), as of Mar 25, the value is 4.29. This value is below the healthy minimum of 5. It has decreased from 12.02 (Mar 24) to 4.29, marking a decrease of 7.73.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.23. This value is within the healthy range. It has decreased from 0.32 (Mar 24) to 0.23, marking a decrease of 0.09.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.32. This value is within the healthy range. It has decreased from 0.42 (Mar 24) to 0.32, marking a decrease of 0.10.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.71. It has decreased from 0.72 (Mar 24) to 0.71, marking a decrease of 0.01.
• For Current Ratio (X), as of Mar 25, the value is 1.87. This value is within the healthy range. It has decreased from 2.07 (Mar 24) to 1.87, marking a decrease of 0.20.
• For Quick Ratio (X), as of Mar 25, the value is 1.05. This value is within the healthy range. It has decreased from 1.43 (Mar 24) to 1.05, marking a decrease of 0.38.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 6.13. This value is within the healthy range. It has increased from 3.96 (Mar 24) to 6.13, marking an increase of 2.17.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 20.66. This value is within the healthy range. It has increased from 11.32 (Mar 24) to 20.66, marking an increase of 9.34.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 11.42. This value is below the healthy minimum of 20. It has increased from 8.87 (Mar 24) to 11.42, marking an increase of 2.55.
• For Earning Retention Ratio (%), as of Mar 25, the value is 79.34. This value exceeds the healthy maximum of 70. It has decreased from 88.68 (Mar 24) to 79.34, marking a decrease of 9.34.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 88.58. This value exceeds the healthy maximum of 70. It has decreased from 91.13 (Mar 24) to 88.58, marking a decrease of 2.55.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 5.83. This value is within the healthy range. It has decreased from 8.86 (Mar 24) to 5.83, marking a decrease of 3.03.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 3.32. This value is within the healthy range. It has decreased from 6.45 (Mar 24) to 3.32, marking a decrease of 3.13.
• For Enterprise Value (Cr.), as of Mar 25, the value is 7,243.45. It has decreased from 7,657.40 (Mar 24) to 7,243.45, marking a decrease of 413.95.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.08. This value is within the healthy range. It has decreased from 1.15 (Mar 24) to 1.08, marking a decrease of 0.07.
• For EV / EBITDA (X), as of Mar 25, the value is 6.99. This value is within the healthy range. It has increased from 4.16 (Mar 24) to 6.99, marking an increase of 2.83.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.78. This value is below the healthy minimum of 1. It has decreased from 0.82 (Mar 24) to 0.78, marking a decrease of 0.04.
• For Retention Ratios (%), as of Mar 25, the value is 79.33. This value exceeds the healthy maximum of 70. It has decreased from 88.67 (Mar 24) to 79.33, marking a decrease of 9.34.
• For Price / BV (X), as of Mar 25, the value is 0.98. This value is below the healthy minimum of 1. It has decreased from 1.09 (Mar 24) to 0.98, marking a decrease of 0.11.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.78. This value is below the healthy minimum of 1. It has decreased from 0.82 (Mar 24) to 0.78, marking a decrease of 0.04.
• For EarningsYield, as of Mar 25, the value is 0.07. This value is below the healthy minimum of 5. It has decreased from 0.20 (Mar 24) to 0.07, marking a decrease of 0.13.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness